(MedPage Today) — The FDA approved a label change for the birth control shot depot medroxyprogesterone acetate (Depo-Provera), which now warns about the risk of meningioma, according to a letter posted on the agency website on Friday.
The new…
Football success did not drive decisions, says Spurs chief
Football success did not drive decisions, says Spurs chief Source: www.channelnewsasia.com






